The latest webinar presentations from OmniaBio’s cell and gene therapy subject matter experts.
CAR T manufacturing intensification: the next wave of CAR T commercialization
Since the commercialization of the first CAR T cell therapies, these revolutionary treatments have reshaped the landscape of cancer therapy, offering unprecedented hope to patients with hematologic malignancies. Listen to the panel of industry and healthcare sector experts discuss the critical intersection of commercialization strategies and manufacturing technology in advancing the next wave of CAR T cell therapies to market.
In this webinar, the panelists will discuss these critical aspects to advance CAR T cell therapy commercialization:
- Navigating commercialization challenges for CAR T cell therapies through manufacture and final product delivery to patients
- Advancements in regulations and market dynamics accelerating CAR T commercialization
- CAR T manufacturing intensification to meet scale and quality demands
- Technology advancements, such as AI, robotics, process analytical technology and rapid release testing to streamline production and improve efficiency
